Fennec Pharmaceuticals Inc.
FRX.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.18M | 36.79M | 21.95M | 18.71M | 22.68M |
| Total Receivables | 18.76M | 23.22M | 19.34M | 17.50M | 15.45M |
| Inventory | 1.86M | 1.57M | 2.48M | 2.20M | 1.40M |
| Prepaid Expenses | 3.46M | 3.74M | 1.40M | 1.42M | 2.44M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.62M | 1.73M | 898.00K | 965.00K | 1.00M |
| Total Current Assets | 66.88M | 67.04M | 46.06M | 40.79M | 42.98M |
|
|
|||||
| Total Current Assets | 66.88M | 67.04M | 46.06M | 40.79M | 42.98M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.94M | 3.51M | 3.20M | 4.08M | 3.43M |
| Total Assets | 71.82M | 70.55M | 49.26M | 44.88M | 46.40M |
|
|
|||||
| Total Accounts Payable | 6.28M | 4.64M | 5.87M | 5.94M | 5.28M |
| Total Accrued Expenses | 3.06M | 5.64M | 3.70M | 2.23M | 2.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 248.00K | 248.00K | 248.00K | 248.00K | 248.00K |
| Total Other Current Liabilities | 248.00K | 248.00K | 248.00K | 248.00K | 248.00K |
| Total Current Liabilities | 9.59M | 10.52M | 9.82M | 8.41M | 8.37M |
|
|
|||||
| Total Current Liabilities | 9.59M | 10.52M | 9.82M | 8.41M | 8.37M |
| Long-Term Debt | -- | -- | 19.38M | 19.36M | 19.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.56M | 24.56M | 24.56M | 24.56M | 24.56M |
| Total Liabilities | 34.15M | 35.08M | 53.75M | 52.34M | 52.28M |
|
|
|||||
| Common Stock & APIC | 265.65M | 263.65M | 218.90M | 215.29M | 213.72M |
| Retained Earnings | -229.22M | -229.42M | -224.64M | -224.00M | -220.85M |
| Treasury Stock & Other | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M |
| Total Common Equity | 37.68M | 35.47M | -4.49M | -7.46M | -5.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.68M | 35.47M | -4.49M | -7.46M | -5.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 37.68M | 35.47M | -4.49M | -7.46M | -5.88M |
|
|
|||||